logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Bipolar Disorder

    FiltersReset Filters
    41 results
    • aripiprazole

      (Aripiprazole oral)
      Camber Pharmaceuticals, Inc.
      Usage: Aripiprazole oral solution is indicated for treating schizophrenia, acute manic and mixed episodes in Bipolar I Disorder, irritability associated with autistic disorder, and Tourette’s disorder.
    • aripiprazole

      (Aripiprazole)
      Ascend Laboratories, LLC
      Usage: Aripiprazole Oral Tablets are indicated for treating schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, as an adjunctive treatment for Major Depressive Disorder, irritability associated with autistic disorder, and Tourette’s disorder.
    • aripiprazole

      (Aripiprazole)
      Amneal Pharmaceuticals LLC
      Usage: Aripiprazole oral solution is indicated for treating schizophrenia, acute manic and mixed episodes in Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.
    • asenapine

      (asenapine maleate)
      Greenstone LLC
      Usage: Asenapine sublingual tablets are indicated for the treatment of schizophrenia in adults and bipolar I disorder, including acute manic or mixed episodes in patients aged 10 to 17. It is also used as adjunctive treatment with lithium or valproate and for maintenance monotherapy in adults.
    • asenapine

      (Asenapine)
      Alembic Pharmaceuticals Limited
      Usage: Asenapine is indicated for Bipolar I disorder, including acute monotherapy of manic or mixed episodes in pediatric patients aged 10 to 17 years, and as adjunctive treatment with lithium or valproate in adults.
    • chlorpromazine hydrochloride

      (chlorpromazine hydrochloride)
      Camber Pharmaceuticals, Inc.
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, and relieving restlessness before surgery. It also addresses acute intermittent porphyria, aids in tetanus treatment, manages mania, treats intractable hiccups, and handles severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.
    • divalproex sodium

      (Divalproex Sodium)
      Aurobindo Pharma Limited
      Usage: Divalproex sodium delayed-release tablets are indicated for treating manic episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in epilepsy (complex partial and absence seizures). They are also used for migraine prophylaxis but not for acute treatment. Not suitable for pregnant women or those planning pregnancy.
    • divalproex sodium

      (Divalproex sodium)
      NorthStar RxLLC
      Usage: Divalproex sodium extended-release tablets are indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Long-term effectiveness in mania is unproven, and the drug is contraindicated in pregnant women due to potential fetal risks.
    • divalproex sodium

      (Divalproex Sodium)
      Unichem Pharmaceuticals (USA), Inc.
      Usage: Divalproex sodium delayed-release tablets are indicated for the treatment of manic episodes in bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Its use in pregnant women or women planning pregnancy is restricted due to potential fetal risks.
    • divalproex sodium

      (divalproex sodium)
      Bionpharma Inc.
      Usage: Divalproex sodium is indicated for treating manic episodes in bipolar disorder, managing complex partial and absence seizures in epilepsy, and for migraine prophylaxis. Long-term efficacy in mania is not established. Use is contraindicated in pregnant women and those of childbearing potential not on effective contraception due to risks of fetal harm.